Predicting Outcomes in Graves’ Orbitopathy
Researchers in Korea recently identified predictive factors for normalization of thyroid-stimulating immunoglobulin levels in moderate-to-severe Graves’ orbitopathy, highlighting the importance of early treatment.
In Thyroid-Associated Orbitopathy, Using Smartphones to Assess Disease Activity
A smartphone-based machine learning-assisted system for evaluating clinical activity in thyroid-associated orbitopathy may represent a promising new approach to the diagnosis and management of this condition.
Asymmetry in Thyroid Eye Disease: Prevalence and Characteristics
Asymmetric disease may occur in one-third of patients with thyroid eye disease, with muscle volume expansion possibly contributing to the asymmetry. A standardized definition of asymmetry using more objective parameters is needed to facilitate comparisons among studies.
Thyroid Eye Disease: Is There a Biomarker for Muscle Enlargement?
Investigators retrospectively reviewed medical records of patients with thyroid eye disease to determine the most useful biomarker for extraocular muscle enlargement.
Graves’ Orbitopathy in Thyroid Cancer: Beware Higher Doses of Radioactive Iodine
A South Korean study followed patients with thyroid cancer to assess for risk of Graves’ orbitopathy, finding an association with radioactive iodine treatment.
In Thyroid Eye Disease, Could This Be a Novel Target?
According to a study from Mayo Clinic, pregnancy-associated plasma protein A has a role in the pathogenesis of thyroid eye disease and may be a more selective target for novel therapies modulating insulin-like growth factor activity, the main driver of TED.